Anthony MS. Phytoestrogens for postmenopausal women's health. Presented at the Congress of Gynaecology; June 22, 2002. Aveiro, Portugal.
Mansfield CA, Hubbell B. The cost of asthma: cost of illness estimates of acute asthma episodes. Presented at the Second World Congress of Environmental and Resource Economists; June 2002. Monterey, CA.
Mansfield CA, Pattanayak SK, McDow W, McDonald R, Halpin P. Shades of green: measuring the value of urban forests in the housing market. Presented at the Second World Congress of Environmental and Resource Economists; June 2002. Monterey, CA.
Ortiz M, Neighbors DM. Collecting evidence of equivalence: implications for economic analyses. Presented at the 2002 ISPOR 7th Annual International Meeting; May 19, 2002. Arlington, VA.
Fehnel SE, McLeod LD. Psychometrics for the non-psychometrician. Presented at the Seventh Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research; May 2002.
Lewis B, Silberman C, Heyes AE. Side effects of chemotherapy among patients with ovarian cancer. Presented at the International Society for Pharmacoeconomics and Outcomes Research 7th Annual International Meeting; May 2002. Washington, DC.
Anthony MS. Soy protein versus isoflavones in the prevention of cardiovascular disease. Presented at the Food as Drug Meeting; April 11, 2002. Turku, Finland.
Dennison CR, Leidy NK, Silberman C, Heyes AE. Interpretation of quality of life data from a clinician's point of view: getting to the clinically meaningful change. Presented at the Mayo Clinic Meeting: Assessing Clinical Significance for Quality of Live Measures in Oncology Research; April 2002. Rochester, MN.
Leidy NK, Jonas D, Silberman C, Margolis MK, Heyes AE. What does it all mean? Using health-related quality of life data to interpret treatment outcomes. Presented at the Mayo Clinic Meeting: Assessing Clinical Significance for Quality of Live Measures in Oncology Research; April 2002. Rochester, MN.
McLeod LD, Fehnel SE, Brandman J, Symonds T. Minimal clinically important differences on the acne-specific quality of life questionnaire (Acne-QoL). Presented at the Drug Information Association's 9th Annual Symposium for Quality of Life Evaluation; March 2002.
Cid Ruzafa J, Arana A, Rueda de Castro AM, Warner BA, Kumar V, O'Sullivan D. Effective prevention of clozaril granulocyte toxicity. Presented at the XII World Congress of Psychiatry; March 2002.
Hollis KA, Duffer A. The use of panels as an effective means of collecting patient-reported outcomes. Presented at the Drug Information Association's 9th Annual Symposium for Quality of Life Evaluation; March 2002.
Mansfield CA, Pattanayak S. Shades of green: relative values of private, neighborhood, and public forests. Presented at the Annual Convention of Allied Social Science Associations; January 2002. Atlanta, GA.